Frameshift Peptides of Children With NF1

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

April 11, 2019

Primary Completion Date

April 27, 2022

Study Completion Date

April 27, 2022

Conditions
Neurofibromatosis Type 1
Interventions
GENETIC

Frameshift Array blood sample test

Patient blood test samples will be collected and evaluated for frameshift peptide mutations.

Trial Locations (3)

20010

Children's National Medical Center, Washington D.C.

30322

Emory University, Atlanta

75390-9020

The University of Texas Southwestern Medical Center, Dallas

All Listed Sponsors
collaborator

University of Texas Southwestern Medical Center

OTHER

collaborator

Arizona State University

OTHER

collaborator

Emory University

OTHER

lead

Children's National Research Institute

OTHER